Načítá se...
Post-trial access to treatment for patients participating in clinical trials
Clinical trials are the mainstay for bringing out newer and better drugs to serve the mankind. By virtue of participating in a clinical trial, a patient receives access to the newer drugs/therapies, but nothing is generally being offered to them once their participation in the study comes to an end....
Uloženo v:
| Vydáno v: | Perspect Clin Res |
|---|---|
| Hlavní autoři: | , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
Medknow Publications & Media Pvt Ltd
2015
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC4394585/ https://ncbi.nlm.nih.gov/pubmed/25878952 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4103/2229-3485.154003 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|